- 89 Downloads
In a case report, a 58-year-old man developed Demodex folliculitis (demodicidosis) following immunosuppression therapy with tacrolimus and mycophenolate-mofetil and during anti-microbial treatment with cotrimoxazole [trimethoprim/sulfamethoxazole], levofloxacin, posaconazole, isoniazid and valaciclovir [valacyclovir] for infectious prophylaxis. Additionally, he developed worsening of rash during treatment with petrolatum [vaseline] and an unspecified barrier creams, and a 45-year-old man developed Demodex folliculitis (demodicidosis) following immunosuppression therapy with tacrolimus and mycophenolate-mofetil. Additionally, both the men developed hair loss during treatment with an unspecified chemotherapy [dosages and duration of treatments to reactions onset not stated; not all routes, indications and outcomes stated].
Patient 1: A 58-year-old man, who was diagnosed with primary myelofibrosis, underwent haploidentical haematopoietic stem cell transplants (HSCT). His immunosuppression...
- Chen C, et al. Sparing of the scalp in severe Demodex folliculitis after stem cell transplantation. JAAD Case Reports 4: 1055-1058, No. 10, Nov 2018. Available from: URL: http://doi.org/10.1016/j.jdcr.2018.09.013 - USA